First Time Loading...

Cortexyme Inc
NASDAQ:CRTX

Watchlist Manager
Cortexyme Inc Logo
Cortexyme Inc
NASDAQ:CRTX
Watchlist
Price: 1.33 USD -5% Market Closed
Updated: May 4, 2024

Cortexyme Inc
Net Income (Common)

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
TTM
|

Cortexyme Inc
Net Income (Common) Peer Comparison

Comparables:
ABBV
GILD
AMGN
VRTX
REGN

Competitive Net Income (Common) Analysis
Latest Figures & CAGR of Competitors

Company Net Income (Common) CAGR 3Y CAGR 5Y CAGR 10Y
Cortexyme Inc
NASDAQ:CRTX
Net Income (Common)
-$51.7m
CAGR 3-Years
N/A
CAGR 5-Years
N/A
CAGR 10-Years
N/A
Abbvie Inc
NYSE:ABBV
Net Income (Common)
$4.8B
CAGR 3-Years
2%
CAGR 5-Years
-3%
CAGR 10-Years
2%
Gilead Sciences Inc
NASDAQ:GILD
Net Income (Common)
$484m
CAGR 3-Years
17%
CAGR 5-Years
-39%
CAGR 10-Years
-20%
Amgen Inc
NASDAQ:AMGN
Net Income (Common)
$6.7B
CAGR 3-Years
-3%
CAGR 5-Years
-4%
CAGR 10-Years
3%
Vertex Pharmaceuticals Inc
NASDAQ:VRTX
Net Income (Common)
$3.6B
CAGR 3-Years
10%
CAGR 5-Years
12%
CAGR 10-Years
N/A
Regeneron Pharmaceuticals Inc
NASDAQ:REGN
Net Income (Common)
$4B
CAGR 3-Years
4%
CAGR 5-Years
10%
CAGR 10-Years
25%

See Also

What is Cortexyme Inc's Net Income (Common)?
Net Income (Common)
-51.7m USD

Based on the financial report for Dec 31, 2022, Cortexyme Inc's Net Income (Common) amounts to -51.7m USD.

What is Cortexyme Inc's Net Income (Common) growth rate?
Net Income (Common) CAGR 1Y
43%

Over the last year, the Net Income (Common) growth was 43%.